Columbia Care Sees Revenue Uptick Despite Retail Closures

May 15, 2023 · Green Market Report

No updates were provided on the timing for sale close.

Columbia Care Inc. (CSE: CCHW) (OTCQX: CCHWF) reported modest first-quarter growth, despite economic headwinds and the closure of several retail locations, according to the cannabis company’s financial results for the period ending March 31, 2023.

The U.S.-based cultivator, manufacturer, and retailer of cannabis products said its top-line revenue grew 1% from the same quarter in 2022 to $124.5 million. The growth beat expectations by $1.3 million and was largely driven by strong performance in the East Coast markets, particularly New Jersey, Virginia, and West Virginia.

In a statement, CEO Nicholas Vita cited the company’s efforts to optimize its portfolio, manage its capital structure, and reduce costs as key factors in its performance.

The company also highlighted the successful launch of its Stash Cash loyalty program and operational changes, including the sale of its Missouri operations and closure of unprofitable Colorado retail locations. While these changes didn’t materially impact first-quarter results, Vita said they will influence future profitability. The company expects to see the effects of its cost-reduction measures, non-core asset divestitures, and improvements in cultivation and manufacturing utilization rates in the coming months.

Columbia Care opened two locations in Virginia and one in West Virginia in the first quarter, contributing to the company’s growth. It has plans for further expansion, with five more dispensaries under development in 2023, including three in Virginia, one in New Jersey, and one in Maryland.

The company maintained its wholesale revenue at $15.2 million in Q1 2023, matching the figure from Q4 2022. However, retail revenue declined 1.5% sequentially due to seasonal factors and the closure of three retail locations at the beginning of the quarter.

In addition to its retail operations, Columbia Care has been focusing on its cultivation and manufacturing capabilities. The company reported a decrease in cultivated cost per gram of more than 11% YoY in Q1 2023 due to operational efficiency gains. It also noted a 4-percentage point increase in its share of concentrates within its wholesale revenue product mix.

Columbia Care ended the quarter with $40.2 million in cash. On March 13, the company divested its interests in the Missouri market for approximately $7 million. Later in March, it extended the maturity date of its 13% senior secured notes from May 2023 to May 2024.

The company said it continues to collaborate closely with Cresco Labs on the divestiture transactions needed to obtain regulatory approvals for the acquisition of Columbia Care. However, no updates were provided on the timing for the execution of agreements regarding outstanding divestiture transactions. (Full Story)

Next Post

Cannabis rebrands aim to differentiate retail, not alienate shoppers

A push toward familiarity and comfort is in, while cannabis shops that resemble the Apple Store appear to be on the way out. Taking a page from contemporary retailers, groceries and restaurants, cannabis companies are overhauling their store interiors to…
Previous Post

Angel tech investor launches Gotham cannabis store with fresh New York City retail look

While people may buy more stuff online, they still like to go out and shop if stores offer them a way to engage their curiosity, a sense of adventure, and a place to gather. That’s what’s helped some retailers compete…
Random Post

Peyote Talk with Jane Fonda, Lily Tomlin and Stephen Colbert

Lily Tomlin is a shaman and she and her acting partner and friend Jane Fonda have taken peyote together, we learned on The Late Show on Mar. 9. Tomlin and Fonda were there to hype their new comedy Moving On, which will be…
Random Post

Cannabis chain once worth $1.7 billion and called the ‘Apple store of weed’ is now nearly failing as the once-hot pot industry faces a major reckoning

A chain of cannabis stores that was once described as the “Apple store of weed” and valued as high as $1.7 billion as a public company, is near financial collapse, according to a regulatory filing. The company, MedMen, said that it has…
Random Post

An Ounce of Prevention Can Stop Financial Distress

It’s a challenging time for cannabis businesses around the country. But for those of us who have been involved since the beginning, what else is new? Today, legal markets exist at some level in the majority of American states. However,…
Random Post

Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit

Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to grow cannabis, reported Reuters. What Happened? The Superior Court of Justice (STJ) made its intentions public to…